BioAtla Company
BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.
Headquarters:
San Diego, California, United States
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
$10M to $50M
Technology:
Cancer
Founded Date:
2007
Industry:
PharmTech